GSK plc (GSK.L)

1.599,00 +15,50 (+0,98%) Al cierre: 05:10PM BST

GSK plc

980 Great West Road
Middlesex
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
https://www.gsk.com

Sector(es): Healthcare
Sector: Drug Manufacturers - General
Empleados a tiempo completo: 70.212

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Ms. Emma Natasha Walmsley	CEO & Director	5,39M	53,92M	1969
Ms. Julie Belita Brown	CFO & Executive Director	5,14M	N/A	1962
Ms. Shobie Ramakrishnan	Chief Digital & Technology Officer	N/A	N/A	1971
Mr. Tony Wood	Chief Scientific Officer and Head of R&D	N/A	N/A	N/A
Ms. Sarah Elton-Farr	Head of Investor Relations	N/A	N/A	N/A
Mr. James Ford	Senior VP & Group General Counsel of Legal & Compliance	N/A	N/A	N/A
Ms. Sally Jackson	Senior Vice President of Global Communications & CEO Office	N/A	N/A	N/A
Mr. David Simon Redfern BSc (Hons), CA	President of Corporate Development	N/A	N/A	1966
Ms. Diana Conrad	Chief People Officer	N/A	N/A	N/A
Mr. Philip C. Thomson	President of Global Affairs	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en GBp.

Descripción

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Gobierno corporativo

El ISS Governance QualityScore de GSK plc, a día 1 de abril de 2024, es 9. Las puntuaciones base son Auditoría: 10; Tablero: 7; Derechos de los accionistas: 1; Compensación: 10.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.